ClinicalTrials.gg
Not yet recruitingNCT07759401FAME-CKDUpdated Aug 12, 2026

Food As Medicine to Reduce CKD Burden in Health Disparity Populations

An interventional study of Culinary Medicine Nutrition and Cooking Education in Chronic Kidney Disease, sponsored by University of Texas Southwestern Medical Center. Not yet recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center — 5 open to participants now, 6 under way, 1 of them phase 3. Renal Insufficiency, Chronic · University of Texas Southwestern Medical Center.

Started
2026
with 1 other
No phase
5 of 11
3 open now
Registered
11th of 11
by date

Among the 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center, this one is one of 2 that started in 2026, is one of 5 with no phase, and was the 11th registered.

Renal Insufficiency, Chronic

3,098 studies on the registry are indexed under Renal Insufficiency, Chronic; 700 are open to participants now.

Browse Renal Insufficiency, Chronic studies →

Open to participants now

5 of the 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 434 Renal Insufficiency, Chronic studies recruiting now, 245 (56%) set no upper age limit and 110 (25%) stop at 75 or younger; 43 take children under 18; 80 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Renal Insufficiency, Chronic by University of Texas Southwestern Medical Center, or all of them as a file.
02

Study summary

Healthy eating plays an important role in kidney and heart health, and programs that use food as medicine can help improve diet and overall health, but the best ways to support healthy eating in community settings are not well understood. The purpose of this study is to compare two study groups to see which is more effective at improving kidney health and related health outcomes in adults with chronic kidney disease. One group receives fruits and vegetables with cooking education, and the other receives fruits and vegetables alone. The results may help researchers develop community-based programs to improve kidney and heart health, especially in populations at higher risk for kidney disease.

If the participant joins the study, the participant will complete a baseline visit, a 6-month visit, and a 12-month visit. Visits include questionnaires about the participant's health, diet, and cooking habits; a urine sample; a blood sample; blood pressure, height, weight, and waist measurements; and a brief, painless Veggie Meter® scan to measure fruit and vegetable intake. Participants will pick up weekly fruits and vegetables for 12 months. Those in the cooking group will also attend 12 weekly cooking and nutrition classes and receive follow-up newsletters and optional monthly virtual sessions. Depending on the group to which the participants are assigned, the total time commitment for the participants in this study will range from approximately 3 to 15 hours.

Participation is voluntary, involves minimal risk, and all information will be kept private. Possible risks include brief pain or bruising from the blood draw, mild discomfort from urine collection, minor risk of cuts or burns during cooking, and some questions may feel personal; the participant may skip any question. There may be no direct benefit to the participant, but the participant's participation may help improve nutrition and kidney health programs in the community.

Read the detailed description

Chronic kidney disease (CKD) impacts approximately 1/7 Americans, who experience asymptomatic progressive CKD leading to catastrophic complications, including kidney failure and death, and this R01 study will extend our previous R21 work to screen, identify , and intervene with culinary medicine philosophy within a community-based setting. The overall goals of the research study are to evaluate (1) urine albumin to creatinine ratio outcomes, (2) secondary endpoints including cardiovascular disease (CVD) measurements (i.e., systolic and diastolic blood pressure, body mass index, hemoglobin A1c, lipids), and (3) dietary adherence and change as well as nutrition knowledge and efficacy. This work will determine whether base-producing fruit and vegetables with or without culinary medicine improves CKD outcomes and associated CVD risk in lower socioeconomic community settings to inform future multi-site trials and population level implementation .

03

Conditions studied

  • Chronic Kidney Disease

Keywords

  • Chronic Kidney Disease
  • CKD
  • Food is Medicine
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • men and women of age ≥ 18 years and able to give consent;
  • willingness to participate in a 12-month study;
  • elevated albumin to creatinine ratio (ACR) (≥ 30 mg/g) determined by point-of-care urine dipstick during health screen;
  • Reside in a low-income area or visit a food pantry due to food insecurity

Exclusion criteria

Exclusion Criteria:

  • whose urine dipstick does not indicate micro- or macro-albuminuria (ACR \<30 mg/g),
  • currently receiving dialysis or need dialysis,
  • have received or need a kidney transplant,
  • pregnant or plan to become pregnant in the next 12 months,
  • baseline urine potassium > 60 mEq/g creatinine (baseline excretion below this level was not associated with hyperkalemia when fruit/vegetable were paired with kidney-protective drugs,
  • urine ACR values indicate nephrotic proteinuria, and
  • CKD stage 5 demonstrated by elevated estimated glomerular filtration rate () obtained during baseline measures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
500 participants (estimated)

Study arms

  • No intervention
    Fruits and Vegetables (FV) Only (Control)

    This group will receive a prescribed amount of free (at no charge) base-producing FV for 12 months through pick-up at one of two Brother Bills Helping Hand (BBHH) sites. BBHH clients pick up groceries weekly from either their main West Dallas campus or the South Dallas Community Market. This calculated FV amount averages 2-3 cups of base-producing FV daily. The FV Only group is considered standard care.

  • Experimental
    Fruits and Vegetables + Nutrition and Cooking education

    Participants will receive the same free base-producing as the FV Only group plus 12 weekly group nutrition and cooking education classes delivered through the UTSW Culinary Medicine program. Classes include hands-on cooking instruction, nutrition education, goal setting, behavioral strategies, and skill-building activities designed to improve healthy eating behaviors, self-efficacy, and motivation.

    Behavioral: Culinary Medicine Nutrition and Cooking Education

Interventions

  • BehavioralCulinary Medicine Nutrition and Cooking Education

    A 12-week group-based culinary medicine program integrating nutrition education, cooking instruction, and behavior change strategies to support healthy eating and meal preparation.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Urine Albumin to Creatinine Ratio at 6 months

    Diagnostic laboratory results for urinalysis will determine whether urine albumin-to-creatinine ratio (UACR) is reduced to a greater extent with the FV + Cook intervention as compared to FV Only at 6- months. High levels of urine albumin excretion predict increased risk for subsequent eGFR decline and its change during follow up is directly associated with risk for End-Stage Kidney Disease (ESKD).

    Time frame: Baseline (enrollment), 6 months

  2. Change in Urine Albumin to Creatinine Ratio at 12 months

    Diagnostic laboratory results for urinalysis will determine whether urine albumin-to-creatinine ratio (UACR) is reduced to a greater extent with the FV + Cook intervention as compared to FV Only at 12-months. High levels of urine albumin excretion predict increased risk for subsequent eGFR decline and its change during follow up is directly associated with risk for ESKD.

    Time frame: Baseline (enrollment), 12 months

Secondary outcomes

  1. Change from Baseline in Systolic and Diastolic Blood Pressure at 6 months

    Systolic blood pressure (SBP) and diastolic blood pressure (DBP) will be measured in millimeters of mercury (mmHg) using a validated instrument according to standardized guidelines. Two to three consecutive readings will be obtained and averaged for analysis. The outcome will be expressed as the mean change from baseline in SBP and DBP at the specified timepoint.

    Time frame: Baseline (enrollment), 6 months

  2. Change from Baseline in Systolic and Diastolic Blood Pressure at 12 Months

    Systolic blood pressure (SBP) and diastolic blood pressure (DBP) will be measured in millimeters of mercury (mmHg) using a validated instrument according to standardized guidelines. Two to three consecutive readings will be obtained and averaged for analysis. The outcome will be expressed as the mean change from baseline in SBP and DBP at the specified timepoint.

    Time frame: Baseline (enrollment), 12 months

  3. Change from Baseline in Glycated Hemoglobin (HbA1c) at 6 months

    HbA1c will be measured as a percentage (%) from venous blood samples using a standardized laboratory method. The outcome will be expressed as the mean change from baseline in HbA1c at the specified timepoint.

    Time frame: Baseline (enrollment), 6 Months

  4. Change from Baseline in Glycated Hemoglobin (HbA1c) at 12 Months

    HbA1c will be measured as a percentage (%) from venous blood samples using a standardized laboratory method. The outcome will be expressed as the mean change from baseline in HbA1c at the specified timepoint.

    Time frame: Baseline (enrollment), 12 months

  5. Change from Baseline in Body Mass Index (BMI) at 6 Months

    Body mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m²). Body weight and height will be measured using standardized procedures, with weight measured using a calibrated scale and height using a stadiometer. The outcome will be expressed as the mean change from baseline in BMI at the specified timepoint.

    Time frame: Baseline (enrollment), 6 Months

  6. Change from Baseline in Body Mass Index (BMI) at 12 Months

    Body mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m²). Body weight and height will be measured using standardized procedures, with weight measured using a calibrated scale and height using a stadiometer. The outcome will be expressed as the mean change from baseline in BMI at the specified timepoint.

    Time frame: Baseline (enrollment), 12 months

  7. Change in LDL Cholesterol (LDL-C) Level From Baseline to 6 months

    LDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in LDL-C (mg/dL or mmol/L) from baseline to 6 months. A reduction in LDL-C from baseline indicates improvement.

    Time frame: Baseline (enrollment), 6 Months

  8. Change in LDL Cholesterol (LDL-C) Level From Baseline to 12 Months

    LDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in LDL-C (mg/dL or mmol/L) from baseline to 12 months. A reduction in LDL-C from baseline indicates improvement.

    Time frame: Baseline (enrollment), 12 months

  9. Change in HDL Cholesterol (HDL-C) Level From Baseline to 6 months

    HDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in HDL-C (mg/dL or mmol/L) from baseline to 6 months. An increase in HDL-C from baseline indicates improvement.

    Time frame: Baseline (enrollment), 6 Months

  10. Change in HDL Cholesterol (HDL-C) Level From Baseline to 12 Months

    HDL cholesterol concentration measured in fasting blood samples using a validated clinical laboratory assay. The outcome is defined as the mean change in HDL-C (mg/dL or mmol/L) from baseline to 12 months. An increase in HDL-C from baseline indicates improvement.

    Time frame: Baseline (enrollment), 12 months

  11. Change in Lipoprotein(a) [Lp(a)] Level From Baseline to 6 months

    Serum lipoprotein(a) concentration measured using a validated laboratory assay. The outcome is defined as the mean change in Lp(a) level (nmol/L or mg/dL) from baseline to 6 months. A reduction in Lp(a) concentration from baseline indicates improvement.

    Time frame: Baseline (enrollment), 6 Months

  12. Change in Lipoprotein(a) [Lp(a)] Level From Baseline to 12 Months

    Serum lipoprotein(a) concentration measured using a validated laboratory assay. The outcome is defined as the mean change in Lp(a) level (nmol/L or mg/dL) from baseline to 6 months. A reduction in Lp(a) concentration from baseline indicates improvement.

    Time frame: Baseline (enrollment), 12 months

Other outcomes

  1. Change in Dietary Intake [total energy intake (kcal/day)]

    Mean daily energy intake calculated from dietary assessment data and expressed as kilocalories per day.

    Time frame: Baseline (enrollment), 6 months

  2. Change in Dietary Intake [total energy intake (kcal/day)]

    Mean daily energy intake calculated from dietary assessment data and expressed as kilocalories per day.

    Time frame: Baseline (enrollment), 12 months

  3. Change in Dietary Intake [total fat intake (g/day)]

    Mean daily total fat intake calculated from dietary assessment data and expressed as grams per day.

    Time frame: Baseline (enrollment), 6 months

  4. Change in Dietary Intake [total fat intake (g/day)]

    Mean daily total fat intake calculated from dietary assessment data and expressed as grams per day.

    Time frame: Baseline (enrollment), 12 months

  5. Change in Dietary Intake [added sugar intake (g/day)]

    Mean daily added sugar intake calculated from dietary assessment data and expressed as grams per day.

    Time frame: Baseline (enrollment), 6 months

  6. Change in Dietary Intake [added sugar intake (g/day)]

    Mean daily added sugar intake calculated from dietary assessment data and expressed as grams per day.

    Time frame: Baseline (enrollment), 12 months

  7. Change in Dietary Intake [sodium intake (mg/day)]

    Mean daily sodium intake calculated from dietary assessment data and expressed as milligrams per day.

    Time frame: Baseline (enrollment), 6 months

  8. Change in Dietary Intake [sodium intake (mg/day)]

    Mean daily sodium intake calculated from dietary assessment data and expressed as milligrams per day.

    Time frame: Baseline (enrollment), 12 months

  9. Change in Dietary Intake [fruit and vegetable consumption (servings/day)]

    Average daily servings of fruits and vegetables derived from dietary assessment data.

    Time frame: Baseline (enrollment), 6 months

  10. Change in Dietary Intake [fruit and vegetable consumption (servings/day)]

    Average daily servings of fruits and vegetables derived from dietary assessment data.

    Time frame: Baseline (enrollment), 12 months

  11. Change in Dietary Intake [selected macro- and micronutrient intake]

    Mean daily intake of selected nutrients, including carbohydrates, protein, fiber, vitamins, and minerals, calculated from dietary assessment data and expressed in standard units (g/day, mg/day, or µg/day, as appropriate).

    Time frame: Baseline (enrollment), 6 months

  12. Change in Dietary Intake [selected macro- and micronutrient intake]

    Mean daily intake of selected nutrients, including carbohydrates, protein, fiber, vitamins, and minerals, calculated from dietary assessment data and expressed in standard units (g/day, mg/day, or µg/day, as appropriate).

    Time frame: Baseline (enrollment), 12 months

  13. Change in Dietary quality

    Diet quality will be calculated from ASA24 dietary recall data using the Diet Quality Index-International (DQI-I). Both the total (summative) DQI-I score and mean DQI-I score will be analyzed, with higher scores indicating better overall diet quality.

    Time frame: Baseline (enrollment), 6 months

  14. Change in Dietary quality

    Diet quality will be calculated from ASA24 dietary recall data using the Diet Quality Index-International (DQI-I). Both the total (summative) DQI-I score and mean DQI-I score will be analyzed, with higher scores indicating better overall diet quality.

    Time frame: Baseline (enrollment), 12 months

  15. Change in skin carotenoid status

    Skin carotenoid status measured by noninvasive spectroscopy. Higher scores indicate greater carotenoid status and are associated with higher fruit and vegetable intake and better overall diet quality.

    Time frame: Baseline (enrollment), 6 months

  16. Change in skin carotenoid status

    Skin carotenoid status measured by noninvasive spectroscopy. Higher scores indicate greater carotenoid status and are associated with higher fruit and vegetable intake and better overall diet quality.

    Time frame: Baseline (enrollment), 12 months

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No — IPD sharing will not be shared with other researchers. Only aggregated, de-identified data will be shared if needed.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2031, 60 months later.

Of 580 non-industry interventional studies with no phase under Renal Insufficiency, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 45. This study's planned 60 months is above that.

Counting every sponsor, half of 620 studies reached it within 23 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2026
First posted
Aug 12, 2026
StartEst.
Oct 2026
Primary completionEst.
Oct 2031
CompletionEst.
Oct 2032
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07759401
Responsible party
Sarah Messiah (Professor, University of Texas Southwestern Medical Center) — Principal investigator
First posted
Aug 12, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2031 (estimated)
Completion
Oct 2032 (estimated)
Last update
Aug 12, 2026

Study contacts

Emilie Ruiz, BS
Contact
emilie.ruiz@utsouthwestern.edu
469-285-6848
Meera J. Patel, PhD
Contact
Meera.Patel@UTSouthwestern.edu
469-852-8557
Sarah Messiah, PhD
principal investigator · University of Texas Southwestern Medical Center
Heather Kitzman, PhD
principal investigator · Parkland Health
Donald Wesson, MD
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion